Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Influenza
Pharma
Moderna's mRNA flu shot nabs FDA nod after earlier review hiccup
Despite a major curveball thrown by the FDA earlier this year, Moderna has managed to strike true with a U.S. approval for its mRNA-based influenza vaccine.
Fraiser Kansteiner
Aug 5, 2026 11:36pm
Sanofi offers commitments to end EU flu shot antitrust probe
Jul 8, 2026 4:26pm
Roche signs generic Xofluza licensing deal with MPP
May 19, 2026 11:15am
RFK Jr., CDC targeted in suit from 15 states over vaccine policy
Feb 25, 2026 8:30am
CDC removes US recommendations for 6 of 17 childhood vaccines
Jan 5, 2026 5:26pm
Its future murky, CSL Seqirus opens $1B vax plant in Australia
Dec 9, 2025 9:08am